For information regarding the U.S. Emergency Use Authorization for remdesivir for pediatric patients less than 12 years of age or weighing less than 40 kg, please click here.

Chat

If you have questions about a product, you can chat live with a Gilead Medical Information Specialist here. This link will open an external page in a new window.

Chat is currently unavailable for Trodelvy.

Our chat service is coming soon. Please utilize other features such as search, call, or inquire to obtain the information you’re requesting.

Search

* required field

Medical Inquiry

To get more information about our products, please provide a few details and our team will contact you.

* required field

Thank you, your inquiry has been submitted.

If you are a patient, please discuss this question and any others you may have about your medical condition, treatment, or medicines with your doctor.

Meeting Request

The ability to request a meeting with a Gilead Medical Scientist is coming soon. Please utilize other features such as search, call, or inquire to obtain the information you’re requesting.

To discuss a question with a Gilead Medical Scientist (MSL), tell us a few details and our team will contact you. You will be contacted for a meeting in approximately 7 business days. If your request is time sensitive, please call us or submit an inquiry.

Trodelvy is currently unavailable for this form.

* required field

Thank you, your request has been submitted.

By clicking “I’m a US healthcare professional”, you’re acknowledging that you’re a healthcare professional practicing in the US. This site is an educational resource for US healthcare professionals and may include products or uses that have not been approved by the US Food and Drug Administration.

OK

You are now leaving the AskGileadMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Gilead Sciences, Inc. does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site, and the opinions, claims, or comments expressed on this site should not be attributed to Gilead Sciences, Inc. Gilead Sciences, Inc. is not responsible for the privacy policy of any third‑party websites.

Click “Continue” to proceed or “Back” to return to AskGileadMedical.com

You are leaving this website

By clicking this link, you will be leaving the Gilead Medical Information website and will be redirected to the Gilead Corporate website.

Once redirected, click on "Global Operations" in the top right corner of the homepage and choose the country you are seeking Gilead product information in.

Welcome to
Gilead Medical Information

This site is an online medical resource that provides access to the most current, accurate, and evidence-based information about Gilead products. The information provided is in response to unsolicited requests and is not intended to be promotional or provide medical advice.

Choose an option that describes you:

By clicking “I’m a USA healthcare professional”, you’re acknowledging that you’re a healthcare professional practicing in the USA. The site you are entering is an educational resource for USA healthcare professionals and may include products or uses that have not been approved by the USA Food and Drug Administration.

Gilead Publications

View publications for the following therapeutic areas.

HIV / AIDS Hematology/ Oncology Inflammation/ Respiratory Liver Diseases Cardiovascular COVID-19